Literature DB >> 16862602

Increasing deaths from opioid analgesics in the United States.

Leonard J Paulozzi1, Daniel S Budnitz, Yongli Xi.   

Abstract

PURPOSE: Since 1990, numerous jurisdictions in the United States (US) have reported increases in drug poisoning mortality. During the same time period, the use of opioid analgesics has increased markedly as part of more aggressive pain management. This study documented a dramatic increase in poisoning mortality rates and compared it to sales of opioid analgesics nationwide.
METHODS: Trend analysis of drug poisoning deaths using underlying cause of death and multiple cause of death mortality data from the Centers for Disease Control and Prevention and opioid analgesic sales data from the US Drug Enforcement Administration.
RESULTS: Unintentional drug poisoning mortality rates increased on average 5.3% per year from 1979 to 1990 and 18.1% per year from 1990 to 2002. The rapid increase during the 1990s reflects the rising number of deaths attributed to narcotics and unspecified drugs. Between 1999 and 2002, the number of opioid analgesic poisonings on death certificates increased 91.2%, while heroin and cocaine poisonings increased 12.4% and 22.8%, respectively. By 2002, opioid analgesic poisoning was listed in 5528 deaths-more than either heroin or cocaine. The increase in deaths generally matched the increase in sales for each type of opioid. The increase in deaths involving methadone tracked the increase in methadone used as an analgesic rather than methadone used in narcotics treatment programs.
CONCLUSIONS: A national epidemic of drug poisoning deaths began in the 1990s. Prescriptions for opioid analgesics also increased in this time frame and may have inadvertently contributed to the increases in drug poisoning deaths.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16862602     DOI: 10.1002/pds.1276

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  236 in total

1.  Prescription of opioids for opioid-naive medical inpatients.

Authors:  Sharan Lail; Kelly Sequeira; Jenny Lieu; Irfan A Dhalla
Journal:  Can J Hosp Pharm       Date:  2014-09

2.  Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse.

Authors:  John S Brownstein; Traci C Green; Theresa A Cassidy; Stephen F Butler
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-06       Impact factor: 2.890

3.  Prescription Drug Abuse & Diversion: Role of the Pain Clinic.

Authors:  Khary K Rigg; Samantha J March; James A Inciardi
Journal:  J Drug Issues       Date:  2010

4.  "I'm not afraid of those ones just 'cause they've been prescribed": perceptions of risk among illicit users of pharmaceutical opioids.

Authors:  Raminta Daniulaityte; Russel Falck; Robert G Carlson
Journal:  Int J Drug Policy       Date:  2012-03-13

5.  Development of a coroner-based surveillance system for drug-related deaths in Los Angeles county.

Authors:  Isabelle Sternfeld; Nicolle Perras; Patti L Culross
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

6.  Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands.

Authors:  Yi Zheng; Samuel Obeng; Huiqun Wang; Abdulmajeed M Jali; Bharath Peddibhotla; Dwight A Williams; Chuanchun Zou; David L Stevens; William L Dewey; Hamid I Akbarali; Dana E Selley; Yan Zhang
Journal:  J Med Chem       Date:  2019-01-11       Impact factor: 7.446

7.  I heard about it from a friend: assessing interest in buprenorphine treatment.

Authors:  Aaron D Fox; Pooja A Shah; Nancy L Sohler; Carolina M Lopez; Joanna L Starrels; Chinazo O Cunningham
Journal:  Subst Abus       Date:  2014       Impact factor: 3.716

8.  The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription.

Authors:  Mark J Edlund; Bradley C Martin; Joan E Russo; Andrea DeVries; Jennifer B Braden; Mark D Sullivan
Journal:  Clin J Pain       Date:  2014-07       Impact factor: 3.442

9.  Gender and comorbidity among individuals with opioid use disorders in the NESARC study.

Authors:  Christine E Grella; Mitchell P Karno; Umme S Warda; Noosha Niv; Alison A Moore
Journal:  Addict Behav       Date:  2009-01-30       Impact factor: 3.913

10.  AMPA receptor positive allosteric modulators attenuate morphine tolerance and dependence.

Authors:  Xiaoyu Hu; Xuebi Tian; Xiao Guo; Ying He; Haijun Chen; Jia Zhou; Zaijie Jim Wang
Journal:  Neuropharmacology       Date:  2018-04-25       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.